Phase II trial assessing the combination of gemcitabine and cisplatin in advanced non-small cell lung cancer (NSCLC)

This publication has 20 references indexed in Scilit:

• 1070: Dose scheduling & drug tolerability in phase II studies of gemcitabine and cisplstin chemotherapy for non-small cell lung cancer
  European Journal Of Cancer, 1997
• Lung cancer mortality among males of Catalonia and Spain compared with other European countries between 1975–1977 and 1987–1989
  International Journal of Cancer, 1996
• 1079 Gemcitabine plus cisplatin in non-small cell lung cancer: A phase II study
  European Journal Of Cancer, 1995
• Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials
  BMJ, 1995
• Prognostic factors in non-small cell lung cancer: Sorensen JB. Department of Oncology, Finsen Center, National University Hospital, 9 Blegdamsvej, DK-2100 Copenhagen. Radiol Oncol 1994;28:301–308
  Lung Cancer, 1995
• A Randomized Trial Comparing Preoperative Chemotherapy Plus Surgery with Surgery Alone in Patients with Non-Small-Cell Lung Cancer
  New England Journal of Medicine, 1994
• Cisplatin-Cyclophosphamide-Mitomycin Combination Chemotherapy With Supportive Care Versus Supportive Care Alone for Treatment of Metastatic Non-Small-Cell Lung Cancer
  JNCI Journal of the National Cancer Institute, 1993
• Chemotherapy of non-small cell lung cancer according to disease extent: a meta-analysis of the literature
  Lung Cancer, 1991
• Epidemiology and Aetiology
  Published by Springer Nature ,1990
• Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer--report of a Canadian multicenter randomized trial.
  Journal of Clinical Oncology, 1988